Lilly Study

Study for patients with CKD, cardiovascular events, and a high BMI

About

The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and established cardiovascular disease (CVD).

Eligibility

Have excess weight
Have heart attack, stroke, or peripheral arterial disease
Have a history of at least 1 self-reported unsuccessful dietary effort to reduce body weight

**There are other requirements for taking part in this study.**

If you qualify, you may receive at no cost: • Close care and follow-up throughout the study. Participants will be compensated for taking part in the study

If you’re interested in participating in one of our Research Studies:

Call

303-232-3366

ext 2150, 2170 or 2190